# Krebs Cycle (Citric Acid Cycle / TCA Cycle)

The **Krebs cycle** â€” also called the **Citric Acid Cycle** or **Tricarboxylic Acid (TCA) Cycle** â€” is the central metabolic hub of aerobic energy production. It occurs in the **mitochondrial matrix** and functions as the convergence point for carbohydrate, fat, and protein catabolism, feeding electrons into the **electron transport chain (ETC)** to generate ATP.

---

## ğŸ”¬ Overview

| Property | Detail |
|---|---|
| **Location** | Mitochondrial matrix |
| **Net inputs (per turn)** | 1 Acetyl-CoA, 3 NADâº, 1 FAD, 1 ADP/GDP, 1 Hâ‚‚O |
| **Net outputs (per turn)** | 2 COâ‚‚, 3 NADH, 1 FADHâ‚‚, 1 GTP (or ATP), 1 CoA-SH |
| **Turns per glucose** | 2 (one per pyruvate â†’ acetyl-CoA) |
| **Total ATP per glucose (via ETC)** | ~20â€“24 ATP from NADH/FADHâ‚‚ generated by TCA |
| **Regulation type** | Substrate availability + allosteric + product inhibition |

---

## âš™ï¸ The Pyruvate â†’ Acetyl-CoA Bridge (Pyruvate Dehydrogenase Complex)

Before entering the Krebs cycle, pyruvate (from glycolysis) must be converted to **Acetyl-CoA**. This irreversible step is performed by the **Pyruvate Dehydrogenase Complex (PDC)**.

```
Pyruvate + CoA + NADâº  â”€â”€[PDC]â”€â”€â–º  Acetyl-CoA + COâ‚‚ + NADH
```

### PDC Cofactor Requirements

| Cofactor | Vitamin Source | Role |
|---|---|---|
| **TPP (Thiamine pyrophosphate)** | Vitamin B1 (Thiamine) | Decarboxylation of pyruvate |
| **Lipoic acid** | Synthesised endogenously; diet | Electron/acyl carrier (oxidised/reduced cycle) |
| **CoA (Coenzyme A)** | Vitamin B5 (Pantothenate) | Acetyl group acceptor |
| **FAD** | Vitamin B2 (Riboflavin) | Reoxidises dihydrolipoamide (E3 subunit) |
| **NADâº** | Vitamin B3 (Niacin) | Final electron acceptor â†’ NADH |

> **Clinical note:** B1 (thiamine) deficiency blocks PDC â†’ pyruvate cannot enter Krebs â†’ ATP production fails â†’ **Wernicke's encephalopathy**, lactic acidosis, cardiac failure.

---

## ğŸ”„ The 8 Steps of the Krebs Cycle

### Complete Reaction Map

```
                     Acetyl-CoA (2C)
                          â”‚
                          â–¼
Oxaloacetate (4C) â”€â”€[1: Citrate synthase]â”€â”€â–º Citrate (6C)
                                                    â”‚
                                      [2: Aconitase]â–¼
                                            Isocitrate (6C)
                                                    â”‚
                               [3: Isocitrate dehydrogenase]â–¼
                                      Î±-Ketoglutarate (5C) + COâ‚‚ + NADH
                                                    â”‚
                           [4: Î±-KG dehydrogenase complex]â–¼
                                     Succinyl-CoA (4C) + COâ‚‚ + NADH
                                                    â”‚
                               [5: Succinyl-CoA synthetase]â–¼
                                       Succinate (4C) + GTP
                                                    â”‚
                                     [6: Succinate dehydrogenase]â–¼
                                          Fumarate (4C) + FADHâ‚‚
                                                    â”‚
                                           [7: Fumarase]â–¼
                                             Malate (4C) + Hâ‚‚O
                                                    â”‚
                                     [8: Malate dehydrogenase]â–¼
                                      Oxaloacetate (4C) + NADH
                                           â”‚
                                     â—„â”€â”€â”€ cycle repeats
```

---

### Step-by-Step Detail

| Step | Enzyme | Reaction | Cofactors | Output | Regulation |
|---|---|---|---|---|---|
| **1** | **Citrate synthase** | Oxaloacetate (4C) + Acetyl-CoA (2C) â†’ Citrate (6C) + CoA | CoA-SH | Citrate | Inhibited by ATP, NADH, succinyl-CoA, citrate |
| **2** | **Aconitase** | Citrate â‡Œ Isocitrate (via cis-aconitate) | Fe-S cluster (non-haem iron) | Isocitrate | Inhibited by fluorocitrate (aconite toxin) |
| **3** | **Isocitrate dehydrogenase** | Isocitrate â†’ Î±-Ketoglutarate + COâ‚‚ + NADH | NADâº, MnÂ²âº or MgÂ²âº | NADH, COâ‚‚ | Activated by ADP, CaÂ²âº; inhibited by ATP, NADH |
| **4** | **Î±-Ketoglutarate (Î±-KG) dehydrogenase complex** | Î±-KG â†’ Succinyl-CoA + COâ‚‚ + NADH | TPP (B1), Lipoic acid, CoA (B5), FAD (B2), NADâº (B3) | NADH, COâ‚‚ | Inhibited by succinyl-CoA, NADH, ATP; activated by CaÂ²âº |
| **5** | **Succinyl-CoA synthetase** | Succinyl-CoA â†’ Succinate + GTP | MgÂ²âº, GDP/ADP + Páµ¢ | **GTP** (or ATP) | Substrate-level phosphorylation |
| **6** | **Succinate dehydrogenase (Complex II)** | Succinate â†’ Fumarate + FADHâ‚‚ | FAD (B2), Fe-S clusters, CoQ10 | **FADHâ‚‚** | Inhibited by oxaloacetate, malonate |
| **7** | **Fumarase (Fumarate hydratase)** | Fumarate + Hâ‚‚O â†’ L-Malate | None | Malate | Minor; product inhibition |
| **8** | **Malate dehydrogenase** | L-Malate â†’ Oxaloacetate + NADH | NADâº | **NADH** | Equilibrium strongly favours malate; pulled by citrate synthase |

---

## ğŸ“Š Net Yield Per Acetyl-CoA (1 Turn)

| Product | Quantity | Energy contribution |
|---|---|---|
| **NADH** | 3 | ~7.5 ATP each via Complex I â†’ ~22.5 ATP |
| **FADHâ‚‚** | 1 | ~1.5 ATP via Complex II â†’ ~1.5 ATP |
| **GTP** | 1 | â‰ˆ 1 ATP (directly) |
| **COâ‚‚** | 2 | Waste (excreted via respiration) |
| **Net ATP per turn** | **~25 ATP** | (theoretical maximum) |

> Per **glucose** (2 turns): ~20â€“24 ATP from TCA products (accounting for proton leak and efficiency losses in vivo).

---

## ğŸ§¬ Cofactor Dependencies â€” Full Reference

| Cofactor | Vitamin / Mineral | Steps Required | Deficiency Consequence |
|---|---|---|---|
| **NADâº** | B3 (Niacin) | Steps 3, 4, 8 (Ã—3 NADH) | â†“ TCA flux â†’ â†“ ATP â†’ Pellagra; lactic acidosis |
| **FAD** | B2 (Riboflavin) | Step 4 (Î±-KG DH), Step 6 (SDH) | â†“ FADHâ‚‚ â†’ â†“ ETC Complex II input |
| **CoA (Coenzyme A)** | B5 (Pantothenate) | PDC bridge + Step 4 + Step 5 | â†“ Acetyl-CoA entry; impaired fatty acid oxidation |
| **TPP (Thiamine pyrophosphate)** | B1 (Thiamine) | PDC bridge, Step 4 (Î±-KG DH) | Wernicke's, lactic acidosis, â†“ Î±-KG â†’ â†“ glutamate/GABA |
| **Lipoic acid** | Endogenous / diet | PDC bridge, Step 4 | Impaired PDC and Î±-KG DH function |
| **Fe-S clusters (aconitase)** | Iron (FeÂ²âº) | Step 2 | â†“ Citrate â†’ isocitrate conversion; TCA block |
| **MgÂ²âº** | Magnesium | Steps 3, 5 (enzyme cofactors) | â†“ Isocitrate DH, succinyl-CoA synthetase activity |
| **MnÂ²âº** | Manganese | Step 3 (Isocitrate DH in some species) | Minor; usually MgÂ²âº is primary in humans |
| **CaÂ²âº** | Calcium | Activation of Steps 3, 4 (mitochondrial) | â†“ TCA activation during muscle contraction/signalling |
| **CoQ10 (Ubiquinone)** | Endogenous; diet/supplements | Step 6 (SDH â†’ ETC handoff) | â†“ FADHâ‚‚ â†’ ETC transfer; statin-induced CoQ10 depletion |

---

## ğŸ”— Connections to Neurotransmitter Synthesis

The Krebs cycle is directly upstream of several neurotransmitter pathways:

| Krebs Intermediate | NT Pathway Connection |
|---|---|
| **Î±-Ketoglutarate (Î±-KG)** | Transaminated â†’ **Glutamate** (â†’ GABA via GAD); major excitatory NT precursor |
| **Oxaloacetate (OAA)** | Transaminated â†’ **Aspartate** (precursor to pyrimidines and asparagine; excitatory NT) |
| **Succinyl-CoA** | Required for **haem synthesis** (haemoglobin, cytochromes, myoglobin) |
| **Acetyl-CoA (entry point)** | Also substrate for **Acetylcholine synthesis** (via ChAT: Acetyl-CoA + Choline â†’ ACh) |
| **GTP (Step 5)** | Substrate for **BH4 synthesis** (GCH1 step) â†’ BH4 is cofactor for TPH (serotonin) and TH (dopamine) |
| **NADH / NADPH** | Powers **BH4 recycling** (DHPR uses NADH; DHFR uses NADPH) |

```
Krebs Cycle
    â”‚
    â”œâ”€â”€ Î±-KG â”€â”€â–º Glutamate â”€â”€â–º GABA
    â”‚                       â””â”€â”€â–º Glutamine
    â”‚
    â”œâ”€â”€ GTP â”€â”€â”€â”€â–º BH4 â”€â”€â–º Serotonin (TPH), Dopamine (TH), NE, EPI
    â”‚
    â”œâ”€â”€ Acetyl-CoA â”€â”€â–º Acetylcholine (ChAT)
    â”‚
    â””â”€â”€ NADH â”€â”€â–º ETC â”€â”€â–º ATP (powers all NT synthesis, vesicle loading, axonal transport)
```

---

## ğŸ”€ Anaplerosis â€” Replenishing the Cycle

Since intermediates are constantly **drained** for biosynthesis (glutamate, aspartate, haem, etc.), they must be replenished. This is called **anaplerosis**:

| Anaplerotic Reaction | Enzyme | Source |
|---|---|---|
| Pyruvate + COâ‚‚ â†’ Oxaloacetate | **Pyruvate carboxylase** (requires Biotin/B7) | Gluconeogenesis, lactate |
| Amino acids â†’ Î±-KG (e.g. Glutamate â†’ Î±-KG) | Glutamate dehydrogenase, aminotransferases | Protein catabolism |
| Propionyl-CoA â†’ Succinyl-CoA | Methylmalonyl-CoA mutase (requires B12) | Odd-chain fatty acids, valine, isoleucine, methionine |
| Aspartate â†’ OAA | Aspartate aminotransferase | Amino acid catabolism |
| Fatty acids (even-chain) | Î²-oxidation â†’ Acetyl-CoA | Fat catabolism (not strictly anaplerotic) |

> **Note:** B7 (Biotin) deficiency impairs pyruvate carboxylase â†’ OAA cannot be replenished â†’ TCA cycle slows â†’ â†“ gluconeogenesis and â†“ energy. B12 deficiency impairs propionyl-CoA â†’ succinyl-CoA â†’ odd-chain fat catabolism blocked (methylmalonic aciduria).

---

## ğŸ§ª Cataplerosis â€” Draining Intermediates for Biosynthesis

| Intermediate Drained | Used For |
|---|---|
| **Acetyl-CoA** | Fatty acid synthesis, cholesterol, ketone bodies, Acetylcholine |
| **Î±-Ketoglutarate** | Glutamate, Glutamine, GABA, proline, arginine synthesis |
| **Oxaloacetate** | Gluconeogenesis (via PEP carboxykinase), aspartate |
| **Succinyl-CoA** | Haem/porphyrin synthesis; ketone body activation |
| **Citrate** | Fatty acid synthesis (exported to cytoplasm â†’ ATP citrate lyase â†’ Acetyl-CoA) |
| **Malate** | Gluconeogenesis; NADPH production (via malic enzyme) |

---

## ğŸš¦ Regulation

The Krebs cycle is tightly regulated by **energy charge** (ATP:ADP:AMP ratio) and **redox state** (NADH:NADâº):

### Key Regulatory Points

| Enzyme | Activated By | Inhibited By |
|---|---|---|
| **Citrate synthase** | ADP, substrate availability | ATP, NADH, succinyl-CoA, citrate |
| **Isocitrate dehydrogenase** | ADP, CaÂ²âº (mitochondrial) | ATP, NADH |
| **Î±-KG dehydrogenase complex** | CaÂ²âº, ADP | ATP, NADH, succinyl-CoA |
| **PDC (upstream bridge)** | CaÂ²âº, insulin (activates PDC phosphatase) | ATP, NADH, acetyl-CoA (product inhibition); PDC kinase (phosphorylation inactivates) |

> **CaÂ²âº as activator:** During muscle contraction or neuronal firing, intracellular CaÂ²âº rises â†’ activates isocitrate DH and Î±-KG DH â†’ accelerates TCA â†’ more ATP produced to meet demand. This is a direct link between neuronal activity and mitochondrial energy production.

### Feedback Summary

```
High ATP/NADH (energy replete)
    â”‚
    â”œâ”€â”€ Inhibits Citrate synthase â†’ â†“ cycle entry
    â”œâ”€â”€ Inhibits Isocitrate DH â†’ â†“ Step 3
    â””â”€â”€ Inhibits Î±-KG DH â†’ â†“ Step 4
          â†’ TCA slows â†’ NADH/ATP production drops â†’ cycle resumes when demand rises
```

---

## ğŸš¨ Clinical Consequences of Krebs Cycle Disruption

| Deficiency / Condition | Primary Block | Consequence |
|---|---|---|
| **Thiamine (B1) deficiency** | PDC + Î±-KG DH paralysed | Lactic acidosis, â†“ ATP, â†“ glutamate/GABA; Wernicke's encephalopathy (neuronal ATP failure) |
| **Riboflavin (B2) deficiency** | â†“ FAD â†’ â†“ Î±-KG DH + â†“ SDH | Reduced TCA throughput; impaired ETC Complex II |
| **Niacin (B3) deficiency** | â†“ NADâº â†’ Steps 3, 4, 8 blocked | Pellagra (dermatitis, diarrhoea, dementia); mitochondrial failure |
| **Pantothenate (B5) deficiency** | â†“ CoA â†’ â†“ Acetyl-CoA entry + Step 4 | Burning feet syndrome; â†“ ACh synthesis; global energy failure |
| **Biotin (B7) deficiency** | â†“ Pyruvate carboxylase â†’ â†“ OAA anaplerosis | Ketoacidosis, â†“ gluconeogenesis, TCA intermediate depletion |
| **Vitamin B12 deficiency** | â†“ Methylmalonyl-CoA mutase â†’ propionyl-CoA accumulates | Methylmalonic aciduria; odd-chain fatty acid accumulation (neurotoxic); succinyl-CoA depletion |
| **Iron deficiency** | â†“ Aconitase (Fe-S clusters) + â†“ haem | Impaired isocitrate â†’ Î±-KG; â†“ cytochrome c â†’ ETC block |
| **Magnesium deficiency** | â†“ Isocitrate DH, succinyl-CoA synthetase | Reduced TCA flux; impaired ATP synthesis |
| **Arsenic poisoning** | Inhibits lipoic acid (blocks PDC + Î±-KG DH) | Severe lactic acidosis; multi-organ failure |
| **Fluoroacetate (rat poison)** | Converted to fluorocitrate â†’ inhibits aconitase | Citrate accumulation; TCA block; fatal |
| **SDHB/SDHC/SDHD mutations** | Succinate dehydrogenase deficiency | Hereditary paraganglioma/phaeochromocytoma; succinate accumulates (oncometabolite) |
| **Mitochondrial disease (mtDNA)** | ETC complex defects â†’ â†‘ NADH:NADâº â†’ TCA product inhibition | Lactic acidosis, Leigh syndrome, MELAS |

---

## ğŸ§  Krebs Cycle and the Brain

The brain is almost entirely dependent on **oxidative phosphorylation** (fuelled by TCA), consuming ~20% of total body oxygen despite being 2% of body weight. Neurons have very limited glycolytic reserve.

| Neurological Connection | Mechanism |
|---|---|
| **Energy for all neurotransmitter synthesis** | ATP powers amino acid uptake, enzymatic synthesis, vesicle packaging |
| **Glutamate/GABA homeostasis** | Î±-KG â†” Glutamate â†” GABA; Krebs intermediates feed this directly |
| **Acetylcholine synthesis** | Acetyl-CoA (TCA entry metabolite) is the direct substrate for ChAT |
| **BH4 production (â†’ dopamine, serotonin)** | GTP produced at Step 5 is substrate for GCH1 (BH4 synthesis) |
| **BH4 recycling** | NADPH (via malic enzyme from malate) and NADH (DHPR) are TCA-linked |
| **Nitric oxide (NO)** | nNOS requires BH4; impaired TCA â†’ â†“ GTP â†’ â†“ BH4 â†’ â†“ NO + NOS uncoupling |
| **Axonal transport** | Kinesin/dynein motors require ATP; TCA failure â†’ transport arrest â†’ neurodegeneration |
| **Calcium signalling** | CaÂ²âº activates TCA (Steps 3, 4); reciprocally, TCA failure â†’ dysregulated CaÂ²âº |

---

## ğŸ’Š Pharmacological and Supplementation Relevance

| Supplement / Drug | Mechanism | Krebs Relevance |
|---|---|---|
| **CoQ10** | ETC electron carrier (FADHâ‚‚ â†’ Complex III) | Supports SDH (Step 6) â†’ ETC handoff; statin-depleted |
| **Alpha-Lipoic Acid (ALA)** | Cofactor for PDC + Î±-KG DH; antioxidant | Supports 2 critical TCA entry/flow steps |
| **B-complex vitamins** | B1/B2/B3/B5 are direct TCA cofactors | Comprehensive Krebs support |
| **Magnesium glycinate** | MgÂ²âº for isocitrate DH + succinyl-CoA synthetase | Removes rate-limiting factor in many depleted individuals |
| **N-Acetyl Cysteine (NAC)** | Antioxidant; protects mitochondrial proteins | Prevents oxidative inactivation of Fe-S enzymes (aconitase) |
| **Creatine** | Phosphocreatine â†” ATP buffer; spares TCA demand | Reduces acute ATP deficit during TCA insufficiency |
| **L-Carnitine** | Fatty acid transport into mitochondria | Maximises Acetyl-CoA supply for TCA cycle |
| **Succinic acid** | TCA intermediate; directly enters at Step 6 | Experimental in mitochondrial disease; bypasses upstream blocks |
| **Metformin** | Inhibits Complex I â†’ â†‘ NADH:NADâº â†’ TCA slowdown | Reduces hepatic gluconeogenesis (OAA diverted less) |
| **Statins** | Deplete CoQ10 (via mevalonate pathway) | Impairs SDH â†’ ETC electron transfer; myopathy risk |

---

## ğŸ½ï¸ Dietary Sources of Krebs Cofactors

| Nutrient | Food Sources | RDA (Adult) |
|---|---|---|
| **B1 (Thiamine)** | Pork, legumes, fortified cereals, sunflower seeds | 1.1â€“1.2 mg/day |
| **B2 (Riboflavin)** | Liver, dairy, eggs, almonds, mushrooms | 1.1â€“1.3 mg/day |
| **B3 (Niacin / NADâº)** | Liver, chicken, tuna, peanuts, mushrooms | 14â€“16 mg NE/day |
| **B5 (Pantothenate / CoA)** | Liver, sunflower seeds, mushrooms, avocado | 5 mg/day (AI) |
| **B7 (Biotin)** | Eggs (cooked), liver, nuts, seeds | 30 Âµg/day (AI) |
| **B12** | Meat, fish, shellfish, dairy, eggs | 2.4 Âµg/day |
| **Lipoic acid** | Red meat, liver, spinach, broccoli | No formal RDA (endogenous synthesis + diet) |
| **CoQ10** | Organ meats, fatty fish, peanuts, soybeans | No RDA; 100â€“300 mg therapeutic |
| **Iron (FeÂ²âº)** | Red meat, shellfish, legumes, spinach | 8 mg (M) / 18 mg (F premenopausal) |
| **Magnesium** | Nuts, seeds, legumes, dark leafy greens | 310â€“420 mg/day |

---

## ğŸ“Š Integration with Other Metabolic Pathways

```
Glycolysis â†’ Pyruvate â”€â”€[PDC: B1, B2, B3, B5, Lipoate]â”€â”€â–º Acetyl-CoA â”€â”€â–º TCA Cycle
                                                                                 â”‚
                          Î²-Oxidation (Fatty acids) â”€â”€â–º Acetyl-CoA â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                                                                 â”‚
                    Amino acid catabolism â”€â”€â–º Î±-KG, OAA, Succinyl-CoA â”€â”€â”€â”€â”€â”€â”€â”€â”€â–ºâ”˜
                                                                                 â”‚
                                                                              TCA Cycle
                                                                                 â”‚
                                          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
                                          â”‚                                       â”‚
                                       3 NADH                                 1 FADHâ‚‚
                                       1 GTP                                       â”‚
                                          â”‚                                        â”‚
                              Electron Transport Chain (ETC)                      ETC
                                          â”‚
                                       ~25â€“30 ATP per glucose equivalent
                                          â”‚
                         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                         â”‚                                   â”‚
                    ATP for synthesis              Biosynthetic drains
                    (NT synthesis,                 (Glutamate, GABA, haem,
                     vesicle transport,             acetyl-CoA for lipids,
                     ion pumps)                     BH4 via GTP, ACholine)
```

---

## âš ï¸ Signs of Impaired Krebs Cycle Function

| Symptom Pattern | Likely Block | Key Missing Nutrient |
|---|---|---|
| Chronic fatigue + brain fog + lactic acidosis | PDC block | B1 (Thiamine) |
| Fatigue + neuropathy + methylmalonic acidâ†‘ | Anaplerosis (propionyl-CoA â†’ succinyl-CoA) | B12 |
| Pellagra (dermatitis, dementia, diarrhoea) | NADâº depletion (Steps 3, 4, 8) | B3 (Niacin) |
| Muscle weakness + myopathy (especially statin users) | CoQ10 depletion â†’ SDH/ETC block | CoQ10 |
| Burning feet + fatigue + neurological symptoms | CoA depletion | B5 (Pantothenate) |
| Anaemia + fatigue + iron-deficiency neuropathy | Aconitase (Fe-S cluster loss) | Iron |
| Fatigue + hypertension + insulin resistance | MgÂ²âº depletion â†’ multiple TCA enzyme failure | Magnesium |
| Depression + anxiety + low dopamine AND serotonin | â†“ GTP (Step 5) â†’ â†“ BH4 â†’ â†“ TPH + TH | Mitochondrial health (B1, B2, B3, CoQ10) |

---

## Summary

The Krebs cycle is the metabolic engine of the cell. It requires **B1, B2, B3, B5, B7, B12, Iron, Magnesium, CoQ10, and Lipoic acid** as direct cofactors. Its outputs â€” NADH, FADHâ‚‚, and GTP â€” power the ETC (for ATP), BH4 synthesis (for serotonin and dopamine), and acetylcholine production. Impaired TCA function therefore cascades into energy failure, neurotransmitter depletion, and metabolic disease.
